Venous Thromboembolism Prophylaxis

Abstract

Venous thromboembolism (VTE) can occur after major general surgery. Pulmonary embolism is recognized as the most common identifiable cause of death in hospitalized patients in the United States. The risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) is higher in colorectal surgical procedures compared with general surgical procedures. The incidence of venous thromboembolism in this population is estimated to be 0.2 to 0.3%. Prevention of VTE is considered a patient-safety measure in most mandated quality initiatives. The measures for prevention of VTE include mechanical methods (graduated compression stockings and intermittent pneumatic compression devices) and pharmacologic agents. A combination of mechanical and pharmacologic methods produces the best results. Patients undergoing surgery should be stratified according to their risk of VTE based on patient risk factors, disease-related risk factors, and procedure-related risk factors. The type of prophylaxis should be commensurate with the risk of VTE based on the composite risk profile.

Keywords

venous thromboembolism - deep venous thrombosis - pulmonary embolism - prevention - mechanical agents - pharmacologic agents - risk stratification

• References

• 1 McLeod RS, Geerts WH, Sniderman KW , et al; Canadian Colorectal Surgery DVT Prophylaxis Trial investigators. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 2001; 233 (3) 438-444
• 2 Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 2003; 163 (14) 1711-1717
• 3 Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg 1991; 78 (7) 849-852
• 4 Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108 (4) 978-981
• 5 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90 (3) 446-455
• 6 Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?. J R Soc Med 1989; 82 (4) 203-205
• 7 Martino MA, Borges E, Williamson E , et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol 2006; 107 (3) 666-671
• 8 Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17 (4) 259-270
• 9 Dismuke SE, Wagner EH. Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients. JAMA 1986; 255 (15) 2039-2042
• 10 Sutedjo JL, Ng RK, Piazza G, Goldhaber SZ. Medicare's new regulations for deep vein thrombosis as a “never event”: wise or worrisome?. Am J Med 2009; 122 (11) 975-976
• 11 Passman MA. Mandated quality measures and economic implications of venous thromboembolism prevention and management. Am J Surg 2010; 199 (1, Suppl): S21-S31
• 12 Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5 (3) 632-634
• 13 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160 (6) 809-815
• 14 Fleming FJ, Kim MJ, Salloum RM, Young KC, Monson JR. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum 2010; 53 (10) 1355-1360
• 15 Geerts WH, Heit JA, Clagett GP , et al. Prevention of venous thromboembolism. Chest 2001; 119 (1, Suppl): 132S-175S
• 16 Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg 1992; 127 (3) 310-313
• 17 Stratton MA, Anderson FA, Bussey HI , et al. Prevention of venous thromboembolism: adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000; 160 (3) 334-340
• 18 Litter J. Thromboembolism; its prophylaxis and medical treatment; recent advances. Med Clin North Am 1952; 36 (5) 1309-1321
• 19 Lewis Jr CE, Antoine J, Mueller C, Talbot WA, Swaroop R, Edwards WS. Elastic compression in the prevention of venous stasis. A critical reevaluation. Am J Surg 1976; 132 (6) 739-743
• 20 Arcelus JI, Caprini JA, Hoffman KN, Traverso CI, Hoppensteadt D, Fareed J. Modifications of plasma levels of tissue factor pathway inhibitor and endothelin-1 induced by a reverse Trendelenburg position: influence of elastic compression—preliminary results. J Vasc Surg 1995; 22 (5) 568-572
• 21 Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 1999; 86 (8) 992-1004
• 22 Allan A, Williams JT, Bolton JP, Le Quesne LP. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983; 70 (3) 172-174
• 23 Kakkos SK, Daskalopoulou SS, Daskalopoulos ME, Nicolaides AN, Geroulakos G. Review on the value of graduated elastic compression stockings after deep vein thrombosis. Thromb Haemost 2006; 96 (4) 441-445
• 24 Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000; (3) CD001484
• 25 Allwood MJ. The effect of an increased local pressure gradient on blood flow in the foot. Clin Sci (Lond) 1957; 16 (2) 231-239
• 26 Chen AH, Frangos SG, Kilaru S, Sumpio BE. Intermittent pneumatic compression devices—physiological mechanisms of action. Eur J Vasc Endovasc Surg 2001; 21 (5) 383-392
• 27 Comerota AJ, Chouhan V, Harada RN , et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997; 226 (3) 306-313 , discussion 313–314
• 28 Morris RJ, Woodcock JP. Evidence-based compression: prevention of stasis and deep vein thrombosis. Ann Surg 2004; 239 (2) 162-171
• 29 Salzman EW, McManama GP, Shapiro AH , et al. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression. Ann Surg 1987; 206 (5) 636-641
• 30 Proctor MC, Greenfield LJ, Wakefield TW, Zajkowski PJ. A clinical comparison of pneumatic compression devices: the basis for selection. J Vasc Surg 2001; 34 (3) 459-463 , discussion 463–464
• 31 Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost 2005; 94 (6) 1181-1185
• 32 Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database Syst Rev 2008; (4) CD005258
• 33 Wille-Jørgensen P, Rasmussen MS, Andersen BR, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database Syst Rev 2004; (1) CD001217
• 34 Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337 (10) 688-698
• 35 White RH, Ginsberg JS. Low-molecular-weight heparins: are they all the same?. Br J Haematol 2003; 121 (1) 12-20
• 36 Nightingale SL. From the Food and Drug Administration. JAMA 1993; 270 (14) 1672
• 37 Kwon S, Meissner M, Symons R , et al; Surgical Care and Outcomes Assessment Program Collaborative. Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg 2011; 213 (5) 596-603 , e1
• 38 International Multicentre Trial. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 1975; 2 (7924) 45-51
• 39 Kakkar VV, Corrigan TP, Fossard DP, Sutherland I, Thirwell J. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Reappraisal of results of international multicentre trial. Lancet 1977; 1 (8011) 567-569
• 40 McLeod RS, Geerts WH, Sniderman KW , et al; Canadian Colorectal Surgery DVT Prophylaxis Trial investigators. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 2001; 233 (3) 438-444
• 41 Bergqvist D , et al; ENOXACAN Study Group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg 1997; 84 (8) 1099-1103
• 42 Etchells E, McLeod RS, Geerts W, Barton P, Detsky AS. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery. Arch Intern Med 1999; 159 (11) 1221-1228
• 43 National Collaborating Centre for Acute Care. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. London, England: NICE; 2010
• 44 Mismetti P, Laporte S, Darmon JY, Buchmüller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001; 88 (7) 913-930
• 45 Agnelli G, Bergqvist D, Cohen A, Gallus A, Gent M. PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. J Surg 2005; 92 (10) 1212-1220
• 46 American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients antithrombotic therapy and prevention of thrombosis. ACCP Guidelines. 9th ed. Northbrook, IL: American College of Chest Physicians; 2012: s240-242
• 47 Rogers Jr SO, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007; 204 (6) 1211-1221
• 48 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2-3) 70-78
• 49 Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991; 17 (Suppl. 03) 304-312
• 50 Catheline JM, Capelluto E, Gaillard JL, Turner R, Champault G. Thromboembolism prophylaxis and incidence of thromboembolic complications after laparoscopic surgery. Int J Surg Investig 2000; 2 (1) 41-47
• 51 White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90 (3) 446-455
• 52 Agnelli G, Bolis G, Capussotti L , et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006; 243 (1) 89-95
• 53 Alcalay A, Wun T, Khatri V , et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol 2006; 24 (7) 1112-1118
• 54 Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol 2003; 101 (1) 157-163
• 55 Spyropoulos AC, Hussein M, Lin J, Battleman D. Rates of venous thromboembolism occurrence in medical patients among the insured population. Thromb Haemost 2009; 102 (5) 951-957
• 56 Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell Jr DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010; 251 (2) 344-350
• 57 Gangireddy C, Rectenwald JR, Upchurch GR , et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007; 45 (2) 335-341 , discussion 341–342
• 58 Falanga A, Zacharski L. Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol 2005; 16 (5) 696-701
• 59 Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist 2003; 8 (4) 381-388
• 60 Lowinger JS, Maxwell DJ. Heparins for venous thromboembolism prophylaxis—safety issues. Aust Prescr 2009; 32: 108-112
• 61 Lyman GH, Khorana AA, Falanga A , et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25 (34) 5490-5505